Basic Information
| LncRNA/CircRNA Name | ABHD11-AS1 |
| Synonyms | ABHD11-AS1, LINC00035, NCRNA00035, WBSCR26 |
| Region | GRCh38_7:73735038-73736158 |
| Ensemble | ENSG00000225969 |
| Refseq | NR_026690 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | endometrial cancer |
| ICD-0-3 | NA |
| Methods | qPCR, Western blot etc. |
| Sample | endometrial cancer tissues, cell line HEC-1B |
| Expression Pattern | up-regulated |
| Function Description | Compared to normal endometrial tissue, lncRNA ABHD11-AS1 was significantly overexpressed in endometrial carcinoma. |
| Pubmed ID | 29799152 |
| Year | 2018 |
| Title | LncRNA ABHD11-AS1 promotes the development of endometrial carcinoma by targeting cyclin D1 |
External Links
| Links for ABHD11-AS1 | GenBank HGNC NONCODE |
| Links for endometrial cancer | OMIM COSMIC |